Abstract:Nanosizing is a non-specific approach to improve the oral bioavailability of poorly soluble drugs. The decreased particle size of these compounds results in an increase in surface area. The outcome is an increased rate of dissolution, which can lead to a better oral absorption. Standard approaches are bottom-up and top-down techniques. Combinative technologies are relatively new approaches, and they can be described as a combination of a bottom-up process followed by a top-down step. The work presented in this paper can be described as a combination of a non-aqueous freeze drying step (bottom-up), followed by wet ball milling or high pressure homogenization (top-down) to produce fine drug nanocrystals. The crystal habit of the model drug glibenclamide was modified by freeze drying from dimethyl sulfoxide (DMSO)/tert-butanol (TBA) solvent mixtures using different ratios. The resulting drug powders were characterized by scanning electron microscopy (SEM) as well as by X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC). It was shown that the combinative approach can significantly improve the particle size reduction effectiveness of both top-down methods over conventional approaches. Drug lyophilization using DMSO:TBA in 25:75 and 10:90 v/v ratios resulted in a highly porous and breakable material. The milling time to achieve nanosuspensions was reduced from 24h with the jet-milled glibenclamide to only 1h with the modified starting material. The number of homogenization cycles was decreased from 20 with unmodified API to only 5 with the modified drug. The smallest particle size, achieved on modified samples, was 160nm by wet ball milling after 24h and 355nm by high pressure homogenization after 20 homogenization cycles at 1500bar.

Surfactant-Polymer Complexation and Competition on Drug Nanocrystal Surfaces Control Crystallinity

Phase Separation and Crystallization of Binary Nanoparticles Induced by Polymer Brushes

Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches

Nanocrystal technology for drug formulation and delivery

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

Drug-Polymer Nanodroplet Formation and Morphology Drive Solubility Enhancement of GDC-0810

Advances of Combinative Nanocrystal Preparation Technology for Improving the Insoluble Drug Solubility and Bioavailability

Combining Surface Templating and Confinement for Controlling Pharmaceutical Crystallization

Unveiling the Potential of Surface Polymerized Drug Nanocrystals in Targeted Delivery

Nanoparticle Surfactants at Complex Emulsion Interfaces

Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery

Solution Coating of Pharmaceutical Nanothin Films and Multilayer Nanocomposites with Controlled Morphology and Polymorphism

Nano-crystals a comprehensive review on formulation and application perspectives

Polymorph selection of pharmaceutical cocrystals via bench-top and continuous production techniques

A Nanocrystal Platform Based on Metal-Phenolic Network Wrapping for Drug Solubilization

The Evolution of Nanocrystalline Drug Delivery System

Progress in the development of stabilization strategies for nanocrystal preparations

Production of Pure Drug Nanocrystals and Nano Co-Crystals by Confinement Methods.

Combination of co-crystal and nanocrystal techniques to improve the solubility and dissolution rate of poorly soluble drugs

Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system

Surfactant Dependent Evolution of Au-Pd Alloy Nanocrystals from Trisoctahedron to Excavated Rhombic Dodecahedron and Multipod: a Matter of Crystal Growth Kinetics